Status:
COMPLETED
Application of Ultrasound-Guided Thoracic Paravertebral Block in Pulmonary Ablation Surgery
Lead Sponsor:
Affiliated Hospital of Nantong University
Conditions:
Lung Cancer
Eligibility:
All Genders
30-90 years
Phase:
NA
Brief Summary
Local thermal ablation therapy of tumor is a rapidly developing minimally invasive therapy for lung tumors in recent years. This study evaluated the efficacy of thoracic paravertebral block (TPVB) for...
Detailed Description
Lung cancer is a serious threat to human health and life. Local thermal ablation therapy of tumor is the focus of domestic and overseas research in the past decade.Thoracic paravertebral nerve block (...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients diagnosed with lung cancer by imaging examination
- Informed consent of the patient and study approval by the Medical Ethics Committee
- Exclusion criteria
- have a history of psychiatric illness, chronic pain, regular analgesic usage
- have contraindications to performing a TPVB, such as chest wall deformity, severe coagulopathy, local infection
- have allergy to local anaesthetic drugs
Exclusion
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05437718
Start Date
December 1 2021
End Date
June 1 2022
Last Update
June 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China, 226000